艾滋病抗病毒治疗新药绥美凯多少钱

Also known as dolutea, it was approved by the US FDA in 2014 for the treatment of adults and adolescents over 12 years old (weight not less than 40 kilograms) infected with human immunodeficiency virus (HIV, also called AIDS). On January 20, 2018, GlaxoSmithKline China (GSK China) announced that its single-tablet compound preparation Suimeikat was officially launched in mainland China.

Suimeikai is my country's best-selling drug for the treatment of AIDS in the past five years and plays an important role in the field of AIDS treatment. Trimax contains three ingredients: abacavir, lamivudine and dolutegravir. Abacavir and lamivudine are nucleoside reverse transcriptase inhibitors (NRTIs); dolutegravir is an integrase inhibitor (INIs). Existing research shows that one year (48 weeks) after HIV infection treatment, 93% of HIV-infected patients turned negative.

Suimeike has the characteristics of high efficiency, good tolerance, and high resistance barrier. It has also received widespread attention after it was launched in China. Its price is also very popular among everyone. It is understood that the price of the domestic Suimeike original drug is around $3,000. Since it is not covered by medical insurance, patients can only buy it at the original price, which imposes a relatively large financial burden on long-term use.

In addition to domestic original medicines, they are also available in India, with 30 tablets per box, and the price is about $900, which is much lower than the domestic price. Patients can go to regular pharmacies in India to buy them in person. However, for most patients, going abroad is not convenient and they have to face problems such as language barriers and long distances. Therefore, we might as well purchase medicines from regular channels through domestic professional overseas medical consulting service companies (such as Medical Companion Travel), and the quality of the medicines can also be guaranteed.

Recommended related hot articles: /newsDetail/80733.html